Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
NKTR —
NEKTAR THERAPEUTICS
CUSIP: 640268306 · Held by 2 superinvestors · Combined value: $28,000,268
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $20,690,859 | 489,377 | REDUCE | -359,700 |
| 2 | Jim Simons | 0.0% | $7,309,409 | 172,881 | REDUCE | -105,660 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -105,660 | -37.9% |
| Ken Griffin | REDUCE | -359,700 | -42.4% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +31,481 | +12.7% |
| Ken Griffin | ADD | +353,233 | +71.2% |
Who Owns NKTR? Superinvestor Holdings
NEKTAR THERAPEUTICS is held by 2 tracked superinvestors, with a combined position value of $28 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter2 reduced or exited.